| Description Of Item | Correspondence concerning the Therapeutic Substances Act, 1925. Particularly in relation to the Laboratory's arrangement with Duncan Flockhart and Company, Chemists, on the production of vaccines, and the impact of the 1925 Act on the details of that agreement.
Please note further information is contained within the general correspondence series and RCP/LAB/9 (Duncan, Flockhart and Company file). |